A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2006
12/14/2006	WO2006095363A3 Injectable preparations of diclofenic and its pharmaceutically acceptable salts
12/14/2006	WO2006092727A9 Process for the production of calcium compositions in a continuous fluid bed
12/14/2006	WO2006092585A3 Personal lubricant containing polyethylene oxide
12/14/2006	WO2006091442A3 Transdermal systems having control delivery system
12/14/2006	WO2006089211A3 Combat/training antioxidant micronutrient formulation and method of administration
12/14/2006	WO2006084911A3 Improved device for application of medicaments, manufacturing method therefor, and method of treatment
12/14/2006	WO2006080630A8 Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
12/14/2006	WO2006079550A3 Alcohol resistant dosage forms
12/14/2006	WO2006078925A3 A tetracycline metal complex in a solid dosage form
12/14/2006	WO2006072940A3 Controlled long acting release pharmaceutical preparation for use in the oral cavity
12/14/2006	WO2006072067B1 Antimicrobial biomaterial for blood bags
12/14/2006	WO2006047493A3 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
12/14/2006	WO2006036614A3 A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer
12/14/2006	WO2006034147A3 Compositions and methods for the preparation and administration of poorly water soluble drugs
12/14/2006	WO2006023814B1 Effervescent composition including a grape-derived component
12/14/2006	WO2005105035A3 Targeted nanoparticles for drug delivery
12/14/2006	WO2005102292A8 Chitosan embedded or encapsulated capsule
12/14/2006	WO2005079752A3 Controlled release pharmaceutical compositions with improved bioavailability
12/14/2006	WO2005053644A8 A medical product comprising tiotropium in a moisture-proof container
12/14/2006	WO2004108069A3 Compositions and methods for promoting neuronal outgrowth
12/14/2006	WO2004093794A3 Antimicrobial medical articles containing a combination of anti-infective compounds, octoxyclycerin, salicylic acid, and sesquiterpenoids
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060282123 Electrical devices and anti-scarring agents
12/14/2006	US20060282062 Methods and systems for neural maintenance and regeneration
12/14/2006	US20060281937 Stearate composition and method
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281721 HRT formulations
12/14/2006	US20060281694 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents; treatment of gingivitis; platelet aggregation modulation
12/14/2006	US20060281693 Renal function improvement
12/14/2006	US20060281087 Titanium dioxide complex having molecule distinguishability
12/14/2006	US20060280943 Powder coating composition for electrostatic coating of pharmaceutical substrates
12/14/2006	US20060280801 Compositions and method for the reduction of post-operative pain
12/14/2006	US20060280800 Tanaproget compositions containing ethinyl estradiol
12/14/2006	US20060280799 Carrier particles
12/14/2006	US20060280798 Nanoparticles for delivery of a pharmacologically active agent
12/14/2006	US20060280797 methylcellulose and hyaluronic acid; inverse thermal gelling and shear-thinning, thixotropic; biodegradable; for delivery of analgesics, neuroprotectants
12/14/2006	US20060280796 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent
12/14/2006	US20060280795 Specific time-delayed burst profile delivery system
12/14/2006	US20060280794 Solid pharmaceutical preparation
12/14/2006	US20060280793 Oral sustained-release preparation of fasudil hydrochloride
12/14/2006	US20060280792 Attachment of a handle to a solid oral dosage form
12/14/2006	US20060280791 Pharmaceutical formulations
12/14/2006	US20060280790 Pharmaceutical formulations
12/14/2006	US20060280789 Sustained release formulations
12/14/2006	US20060280788 Delivery and formulations of mast cell stabilizers
12/14/2006	US20060280787 Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
12/14/2006	US20060280786 Pharmaceutical formulations for minimizing drug-drug interactions
12/14/2006	US20060280785 Biocidal materials for treatment against pathogens
12/14/2006	US20060280784 amphiphilic substance or a hydrophobic substance is modified with a glycerol derivative, which is useful as a surface modifier for producing a drug carrier; liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal
12/14/2006	US20060280782 Dermal delivery system composition comprising an aqueous base vehicle including Emu oil, at least one fatty acid alkyl ester, polyethylene glycol, and a gelling agent, in combination with a therapeutically effective amount of at least one species of insulin
12/14/2006	US20060280781 Sequestered reactive materials
12/14/2006	US20060280777 Encapsulated energy gel compositions
12/14/2006	US20060280774 Compositions and methods for treating glaucoma
12/14/2006	US20060280771 Drug delivery system
12/14/2006	US20060280770 Coating for implantable devices and a method of forming the same
12/14/2006	US20060280761 Nanofluidized B-12 composition and process for treating pernicious anemia
12/14/2006	US20060280760 Assortment of personal care products having synergistic identifiers communicating products to be purchased together
12/14/2006	US20060280743 Immunoglobulin for treatment of alzheimer's diseases
12/14/2006	US20060280715 Retinoid solutions and formulations made therefrom
12/14/2006	US20060280713 Method for producing porous moulded bodies containing alginate
12/14/2006	US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns
12/14/2006	US20060280691 Spray freeze dried liposomal ciprofloxacin powder aerosol drug delivery
12/14/2006	US20060280690 Methods of preparing a foam comprising a sclerosing agent
12/14/2006	US20060280680 Hybrid nanocrystals for treatment and bioimaging of disease
12/14/2006	US20060280643 Particle-size reduction apparatus and use thereof
12/14/2006	US20060280430 Method for delivering particulate drugs to tissues
12/14/2006	DE102005027333A1 Nanoskalische Reaktivdesorption - ein Verfahren zur Herstellung kolloidalisierter Wirkstoff- bzw. Vitalstoffspezies, insbesondere entsprechender Wirkstoff- bzw. Vitalstoffkonzentraten sowie Vorrichtungen zur Durchführung derselben Nano-earth Reaktivdesorption - a method for producing kolloidalisierter drug or vital substance species, in particular any such drug or vital substance concentrates and apparatus for performing the same
12/14/2006	DE102005022862A1 Kapseln für Inhalatoren Capsules for inhalers
12/14/2006	CA2835901A1 Attachment of a handle to a solid oral dosage form
12/14/2006	CA2611726A1 Pharmaceutical compositions containing sc(fv)2
12/14/2006	CA2611724A1 Stabilized milnacipran formulation
12/14/2006	CA2611451A1 Solid preparation
12/14/2006	CA2611430A1 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/14/2006	CA2611261A1 Crystal of salt of benzimidazole compound
12/14/2006	CA2611083A1 Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying
12/14/2006	CA2610987A1 Stabilizer for protein preparation comprising meglumine and use thereof
12/14/2006	CA2610977A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
12/14/2006	CA2610975A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
12/14/2006	CA2610881A1 Eye drop containing roflumilast
12/14/2006	CA2610755A1 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
12/14/2006	CA2610605A1 Topical ungual formulations
12/14/2006	CA2610495A1 Compositions for drug delivery
12/14/2006	CA2610465A1 Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
12/14/2006	CA2610454A1 Attachment of a handle to a solid oral dosage form
12/14/2006	CA2610448A1 Nanoparticulate imatinib mesylate formulations
12/14/2006	CA2610342A1 Sugar-coated tablet
12/14/2006	CA2609998A1 Oral ribavirin pharmaceutical compositions
12/14/2006	CA2609209A1 Topical oligopeptide delivery system
12/14/2006	CA2608631A1 Method and composition for treating inflammatory disorders
12/14/2006	CA2608226A1 Dried formulations of nanoparticle-coated capsules
12/14/2006	CA2607340A1 Particle size, percent drag efficiency and molecular weight control of bulk polymer polymerized polyalphaolefins using high shear material processors
12/14/2006	CA2604768A1 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
12/13/2006	EP1731183A1 Solid pharmaceutical preparation for dialysis
12/13/2006	EP1731173A1 Complex particles and coated complex particles
12/13/2006	EP1731172A1 Liposome preparation
12/13/2006	EP1731154A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)\|4-(4-pyridylmethyl)pht halazin-1-yl\| and salts thereof
12/13/2006	EP1731153A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl\| and salts thereof
12/13/2006	EP1731152A2 Sustained analgesia achieved with transdermal delivery of buprenorphine
12/13/2006	EP1731151A1 Solid pharmaceutical preparation containing sparingly water-soluble drug
12/13/2006	EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof

1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 2991